Amgen and Dezima Pharma B.V. announced that the companies have entered into a definitive acquisition agreement under which Amgen will...
Teva Pharma UK has launched generic versions of Seroquel and Seroquel XL as Quetiapine and Quetiapine XL.Other generic versions are...
Teva Pharmaceutical Industries Ltd. and Auspex Pharmaceuticals, Inc. announced that they have entered into a definitive merger agreement under which...
The FDA has expanded the indication for Azilect (rasagiline tablets), from Teva Pharma, from monotherapy and adjunct to levodopa (LD)...
Alder BioPharmaceuticals, Inc.announced that it has entered into a European patent settlement and global license agreement with Teva Pharmaceuticals International...
The FDA has approved QNASL (beclomethasone dipropionate) 40 mcg, from Teva Pharma, for the treatment of nasal symptoms associated with...
Starpharma has received marketing approval in the European Union for VivaGel BV for the treatment and rapid relief of bacterial...
Teva Pharmaceutical announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency has recommended...
This systematic review and meta-analysis aimed to determine the effectiveness of brentuximab vedotin (BV) in relapsed/refractory classical Hodgkin lymphoma (R/R cHL) in the clinical practice setting using most recent results.
This phase 1-2 study evaluated brentuximab vedotin (BV) combined with nivolumab (Nivo) as first salvage therapy in patients with relapsed/refractory (r/r) classical Hodgkin lymphoma (cHL).